Universal Health Services, Inc.

NYSE:UHS

Medical - Care Facilities

Healthcare
$186.07 -3.84%

-$5.64 today

Market cap
$9.38B
Beta
1.08
P/E (TTM)
5.7
EPS (TTM)
$24.90
Dividend yield
0.57%
52W Low $140.08High $246.33

Volume 0.67M

Average 0.94M

UHS Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

Universal Health Services, Inc.NYSE: UHS

Capital Expenditures · Q2 FY2026 · quarter ended Jun 2026

Capital expenditures declines year over year

Q2 FY2026 capital expenditures of $227.63M (cash outflow) fell 14.4% year over year, behind the -2.5% change in trailing-twelve-month capital expenditures. Sequentially, it rose 4.8% from the prior quarter. Over 3 fiscal years it compounded at +11.4% a year.

Context

  • Capital expenditures amounted to 5.8% of revenue in FY2025, down 0.1 pp from a year earlier.
  • Capital expenditures grew in size in 3 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -14.4% toward the trailing-twelve-month pace of -2.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$227.63M+4.8% QoQ
Last fiscal yearDec 2025
-$1.02B+7.6% YoY
LTMJun 2026
-$973.58M-2.5% YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-14.4%——
1 year+7.6%——
3-year CAGR+11.4%——
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(1.02B) USD
Year-over-year change
-7.6%

Capital Expenditures vs competitors

How UHS compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -2.5% is the 8th highest of 9, against a peer median of +18.1%.
  • Capital expenditures amounts to 5.4% of revenue for UHS, versus a peer median of 3.0%.
UHS Competitors
Capital Expenditures for UHS and competitors
Company Period LTM YoY 3-year CAGR% of revenue
HCAHCA Healthcare, Inc.LTM Jun 2026$5.13B USD+10.4%+4.0%6.6%
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026€1.03B EUR+46.3%+6.7%5.3%
THCTenet Healthcare CorporationLTM Jun 2026$992M USD+10.0%+9.8%4.5%
UHSUniversal Health Services, Inc.LTM Jun 2026$973.58M USD-2.5%+11.4%5.4%
CYHCommunity Health Systems, Inc.LTM Mar 2026$326M USD-7.4%-6.9%1.5%
ARDTArdent Health Partners, LLCLTM Mar 2026$217.08M USD+16.4%+11.9%3.4%
CHEChemed CorporationLTM Jun 2026$66.35M USD+19.8%+3.1%2.6%
ACHCAcadia Healthcare Company, Inc.LTM Sep 2026$21.93M USD+103.2%+24.5%0.6%
NUTXNutex Health, Inc.LTM Mar 2026$3.66M USD+124.1%-44.3%0.4%
Peer median (excluding UHS) —+18.1%+5.3%3.0%

Competitors are the stored peer set for UHS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income987.63M656.98M717.49M1.16B1.51B
Depreciation & Amortization533.21M581.86M568.04M584.83M618.74M
Deferred Income Tax26.05M0000
Stock-Based Compensation73.69M85.38M87.72M99.35M95.69M
Change in Working Capital(736.89M)(244.35M)17.07M418.76M(275.89M)
Accounts Receivables(8.87M)(258.34M)(182.44M)67.36M(317.99M)
Inventory00000
Accounts Payables00000
Other Working Capital(728.02M)13.99M199.51M351.4M42.09M
Other Non-Cash Items0(83.85M)(124.34M)(198.95M)(85.32M)
Operating Cash Flow883.7M996.02M1.27B2.07B1.86B
Capital Expenditures(855.66M)(734M)(743.06M)(943.81M)(1.02B)
Acquisitions (Net)(105.32M)(20.31M)(3.73M)(18.72M)(31.94M)
Purchases of Investments(1.36M)000(52.21M)
Sales of Investments094.91M000
Other Investing Activities46.51M12M(16.51M)51.42M28.69M
Investing Cash Flow(914.47M)(647.3M)(763.28M)(911.11M)(1.07B)
Debt Repayment217.11M615.95M99.62M(429.75M)241.65M
Common Stock Issued13.37M14.07M13.65M15.07M16.73M
Common Stock Repurchased(1.22B)(832.92M)(547.36M)(670.75M)(967.95M)
Dividends Paid(65.9M)(58.45M)(55.48M)(53.35M)(51.27M)
Other Financing Activities715K(42.99M)9.28M(6.09M)11.11M
Financing Cash Flow(1.07B)(318.4M)(493.95M)(1.14B)(749.73M)
Effect of Forex Changes(499K)(8.42M)3.06M(833K)2.52M
Net Change in Cash(1.1B)21.9M13.63M10.28M46.57M
Free Cash Flow28.04M262.02M524.74M1.12B849.25M

Universal Health Services, Inc.

NYSE:UHS

Intrinsic Alpha fair value

Locked

Current Price

$186.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.